Clinical Trial

Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection

Study acronym: NUTRACOVID
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 9, 2026 (before its estimated July 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
A controlled, randomized clinical trial is proposed to demonstrate the effectiveness of the experimental product in controlling hepato-pulmonary inflammation and neurovascular encephalic inflammation, which may constitute the etiopathogenic basis of persistent COVID. In addition, an individualized training program will be implemented for each participant in order to improve chronic symptoms and, consequently, their quality of life.
Trial Details
NCT Number NCT07397910
Lead Sponsor Universidad Católica San Antonio de Murcia
Conditions Long COVID
Enrollment 40 participants
Start Date 2026-02-23
Primary Completion 2026-07-06 (estimated)
Study Completion 2026-08-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-09